Mitophagy in cancer: a tale of adaptation

M Vara-Perez, B Felipe-Abrio, P Agostinis - Cells, 2019 - mdpi.com
In the past years, we have learnt that tumors co-evolve with their microenvironment, and that
the active interaction between cancer cells and stromal cells plays a pivotal role in cancer …

DNA damage and mitochondria in cancer and aging

J Patel, BA Baptiste, E Kim, M Hussain… - …, 2020 - academic.oup.com
Age and DNA repair deficiencies are strong risk factors for developing cancer. This is
reflected in the comorbidity of cancer with premature aging diseases associated with DNA …

MCL-1 is a prognostic indicator and drug target in breast cancer

KJ Campbell, S Dhayade, N Ferrari, AH Sims… - Cell death & …, 2018 - nature.com
Abstract Analysis of publicly available genomic and gene expression data demonstrates that
MCL1 expression is frequently elevated in breast cancer. Distinct from other pro-survival Bcl …

BCL2L13 promotes mitophagy through DNM1L-mediated mitochondrial fission in glioblastoma

J Wang, A Chen, Z Xue, J Liu, Y He, G Liu, Z Zhao… - Cell Death & …, 2023 - nature.com
There is an urgent need for novel diagnostic and therapeutic strategies for patients with
Glioblastoma multiforme (GBM). Previous studies have shown that BCL2 like 13 (BCL2L13) …

Understanding MCL1: from cellular function and regulation to pharmacological inhibition

M Sancho, D Leiva, E Lucendo, M Orzáez - The FEBS Journal, 2022 - Wiley Online Library
Myeloid cell leukemia‐1 (MCL1), an antiapoptotic member of the BCL2 family characterized
by a short half‐life, functions as a rapid sensor that regulates cell death and other relevant …

Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response

P Godoy, C Cadenas, B Hellwig, R Marchan, J Stewart… - Breast Cancer, 2014 - Springer
Background Recently, interferon-inducible guanylate binding protein (GBP2) has been
discussed as a possible control factor in tumor development, which is controlled by p53, and …

Mitochondria autophagy: a potential target for cancer therapy

YH Qiu, TS Zhang, XW Wang, M Wang… - Journal of drug …, 2021 - Taylor & Francis
Mitophagy is a selective form of macroautophagy in which dysfunctional and damaged
mitochondria can be efficiently degraded, removed and recycled through autophagy …

BCL2L13: physiological and pathological meanings

F Meng, N Sun, D Liu, J Jia, J Xiao, H Dai - Cellular and Molecular Life …, 2021 - Springer
Abstract BCL2L13 is a BCL2-like protein. It has been discovered for two decades, now on
the way to be a hotspot of research with its physiological and pathological meanings found …

A BAG's life: Every connection matters in cancer

E Mariotto, G Viola, C Zanon, S Aveic - Pharmacology & Therapeutics, 2020 - Elsevier
The members of the BCL-2 associated athanogene (BAG) family participate in the regulation
of a variety of interrelated physiological processes, such as autophagy, apoptosis, and …

Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic …

JP Sundberg, TM Stearns, J Joh, M Proctor, A Ingle… - PloS one, 2014 - journals.plos.org
Papillomaviruses (PVs) induce papillomas, premalignant lesions, and carcinomas in a wide
variety of species. PVs are classified first based on their host and tissue tropism and then …